• Mashup Score: 0
    Wolters Kluwer Health - 10 month(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • New in #PAIN: Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of nociplastic pain https://t.co/UCq9PX4r7n

    • New in #PAIN: Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of #nociplastic pain https://t.co/HUAdOfVcNp @kren27

    • New in #PAIN: Stimulated whole-blood cytokine/chemokine responses are associated with interstitial #cystitis/bladder pain syndrome phenotypes and features of #nociplasticpain https://t.co/d8hRdfC5Qx

  • Mashup Score: 0

    Consensus guidelines for ketamine infusions in acute and chronic pain were published in 2018.[1 2][1] Non-medical ketamine use can cause cystitis, rarely requiring cystectomy.[3][2] Data on cystitis in patients receiving ketamine for acute and chronic pain are lacking. The objective of this

    Tweet Tweets with this article
    • Ketamine infusions and bladder complications https://t.co/D15pPUn9Qd #ketamine #pain #cystitis @ESchwenkMD @dr_rajgupta @ASRA_Society https://t.co/6MdnSKiU4n

  • Mashup Score: 1

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • .@jkhastgir offers an update on Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Read Jay's article for #Urology News here > https://t.co/XXKsfWBIai https://t.co/ziQwJTCoCj

  • Mashup Score: 8

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • .@jkhastgir offers an update on Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Read Jay's article for #Urology News here > https://t.co/XXKsfWBIai https://t.co/Dmc3JPjJja

  • Mashup Score: 2

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • .@jkhastgir offers an update on Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Read Jay's article for #Urology News here > https://t.co/XXKsfWTj1Q https://t.co/SrWMk7N1V7

  • Mashup Score: 1

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Tap the link for @jkhastgir's update > https://t.co/qoBZEhRT9e https://t.co/W7LOUwttB1

  • Mashup Score: 0

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Tap the link for @jkhastgir's update > https://t.co/qoBZEi9u0M https://t.co/UtvC2hs3aG

  • Mashup Score: 0

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis Tap the link for @jkhastgir's update > https://t.co/qoBZEhRT9e https://t.co/k1CzSEfxob